Hired Writers, Not Scientists, Behind Merck’s Vioxx Studies
In a new twist to the ethical issues Merck Inc, faces over Vioxx (rofecoxib), the company’s one-time best seller that was pulled from the market in 2004, because it became closely associated with...
View ArticleBad News, Good News on Vioxx Heart Attack Risk
Long-term study of individuals taking Vioxx (rofecoxib) for arthritis and chronic pain has confirmed some bad news associated with the painkiller but it has revealed some good news, too. Vioxx, a...
View Article